世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 臨床CROサービス-世界市場シェアとランキング、全体売上高と需要予測2025-2031年Clinical CRO Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 臨床CROサービスの世界市場規模は2024年に100万米ドルと推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。 臨床 CRO サービスは、主に臨床試験段階... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー臨床CROサービスの世界市場規模は2024年に100万米ドルと推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。臨床 CRO サービスは、主に臨床試験段階の研究のためのサービスを提供するもので、臨床第Ⅰ相から第Ⅳ相の技術サービス、臨床データ管理と統計分析、新薬登録申告などをカバーする。 臨床CROサービスの北米市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に％の年平均成長率で、2031年までに100万ドルに達するでしょう。 臨床CROサービスのアジア太平洋市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に％のCAGRで、2031年までに100万ドルに達するでしょう。 臨床CROサービスのヨーロッパ市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に％のCAGRで、2031年までに100万ドルに達するだろう。 臨床CROサービスの世界の主要企業には、IQVIA、Covance、Parexel、LabCorp、Fountain-Med、PPD、Syneos Health、PRA、Charels River、Medpaceなどが含まれる。2024年には、世界の大手5社が売上高で約 %のシェアを占めています。 本レポートは、臨床CROサービスの世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総売上高、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。 臨床CROサービスの市場規模、推計、予測は、2024年を基準年とし、2020年から2031年までの期間の履歴データと予測データを売上高（百万ドル）で提供しています。定量的および定性的な分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、臨床CROサービスに関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 IQVIA コバンス パレクセル ラボコープ ファウンテンメッド PPD シネオス・ヘルス PRA チャールズ・リバー メドスペース タイガーメド 博慈医療技術有限公司 南京華為医学技術集団有限公司 ジョインラボラトリーズ（中国）有限公司 ケムパートナー 呉西AppTec タイプ別セグメント 臨床試験デザイン 臨床試験の実施 臨床試験分析 その他 アプリケーション別セグメント 化学医薬品の研究開発 細胞・遺伝子治療研究開発 バイオ医薬品研究 その他 地域別 北米 米国 カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章： レポートのスコープ、世界の総市場規模を紹介します。本章では、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析も提供します。 第2章：臨床CROサービス企業の競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章：各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。 第4章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章：地域レベルでの臨床CROサービスの収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、市場規模を紹介しています。 第6章：国別臨床CROサービスの収益。各国・地域のタイプ別、用途別のシグメイトデータを掲載しています。 第7章：主要企業のプロファイルを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Clinical CRO Services Product Introduction 1.2 Global Clinical CRO Services Market Size Forecast (2020-2031) 1.3 Clinical CRO Services Market Trends & Drivers 1.3.1 Clinical CRO Services Industry Trends 1.3.2 Clinical CRO Services Market Drivers & Opportunity 1.3.3 Clinical CRO Services Market Challenges 1.3.4 Clinical CRO Services Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Clinical CRO Services Players Revenue Ranking (2024) 2.2 Global Clinical CRO Services Revenue by Company (2020-2025) 2.3 Key Companies Clinical CRO Services Manufacturing Base Distribution and Headquarters 2.4 Key Companies Clinical CRO Services Product Offered 2.5 Key Companies Time to Begin Mass Production of Clinical CRO Services 2.6 Clinical CRO Services Market Competitive Analysis 2.6.1 Clinical CRO Services Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Clinical CRO Services Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical CRO Services as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Clinical Trial Design 3.1.2 Clinical Trial Execution 3.1.3 Clinical Trial Analysis 3.1.4 Other 3.2 Global Clinical CRO Services Sales Value by Type 3.2.1 Global Clinical CRO Services Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Clinical CRO Services Sales Value, by Type (2020-2031) 3.2.3 Global Clinical CRO Services Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Chemical Drug Research And Development 4.1.2 Cell And Gene Therapy Research And Development 4.1.3 Biopharmaceutical Research 4.1.4 Other 4.2 Global Clinical CRO Services Sales Value by Application 4.2.1 Global Clinical CRO Services Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Clinical CRO Services Sales Value, by Application (2020-2031) 4.2.3 Global Clinical CRO Services Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Clinical CRO Services Sales Value by Region 5.1.1 Global Clinical CRO Services Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Clinical CRO Services Sales Value by Region (2020-2025) 5.1.3 Global Clinical CRO Services Sales Value by Region (2026-2031) 5.1.4 Global Clinical CRO Services Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Clinical CRO Services Sales Value, 2020-2031 5.2.2 North America Clinical CRO Services Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Clinical CRO Services Sales Value, 2020-2031 5.3.2 Europe Clinical CRO Services Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Clinical CRO Services Sales Value, 2020-2031 5.4.2 Asia Pacific Clinical CRO Services Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Clinical CRO Services Sales Value, 2020-2031 5.5.2 South America Clinical CRO Services Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Clinical CRO Services Sales Value, 2020-2031 5.6.2 Middle East & Africa Clinical CRO Services Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Clinical CRO Services Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Clinical CRO Services Sales Value, 2020-2031 6.3 United States 6.3.1 United States Clinical CRO Services Sales Value, 2020-2031 6.3.2 United States Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Clinical CRO Services Sales Value, 2020-2031 6.4.2 Europe Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Clinical CRO Services Sales Value, 2020-2031 6.5.2 China Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.5.3 China Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Clinical CRO Services Sales Value, 2020-2031 6.6.2 Japan Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Clinical CRO Services Sales Value, 2020-2031 6.7.2 South Korea Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Clinical CRO Services Sales Value, 2020-2031 6.8.2 Southeast Asia Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Clinical CRO Services Sales Value, 2020-2031 6.9.2 India Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.9.3 India Clinical CRO Services Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 IQVIA 7.1.1 IQVIA Profile 7.1.2 IQVIA Main Business 7.1.3 IQVIA Clinical CRO Services Products, Services and Solutions 7.1.4 IQVIA Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.1.5 IQVIA Recent Developments 7.2 Covance 7.2.1 Covance Profile 7.2.2 Covance Main Business 7.2.3 Covance Clinical CRO Services Products, Services and Solutions 7.2.4 Covance Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.2.5 Covance Recent Developments 7.3 Parexel 7.3.1 Parexel Profile 7.3.2 Parexel Main Business 7.3.3 Parexel Clinical CRO Services Products, Services and Solutions 7.3.4 Parexel Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.3.5 Parexel Recent Developments 7.4 LabCorp 7.4.1 LabCorp Profile 7.4.2 LabCorp Main Business 7.4.3 LabCorp Clinical CRO Services Products, Services and Solutions 7.4.4 LabCorp Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.4.5 LabCorp Recent Developments 7.5 Fountain-Med 7.5.1 Fountain-Med Profile 7.5.2 Fountain-Med Main Business 7.5.3 Fountain-Med Clinical CRO Services Products, Services and Solutions 7.5.4 Fountain-Med Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.5.5 Fountain-Med Recent Developments 7.6 PPD 7.6.1 PPD Profile 7.6.2 PPD Main Business 7.6.3 PPD Clinical CRO Services Products, Services and Solutions 7.6.4 PPD Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.6.5 PPD Recent Developments 7.7 Syneos Health 7.7.1 Syneos Health Profile 7.7.2 Syneos Health Main Business 7.7.3 Syneos Health Clinical CRO Services Products, Services and Solutions 7.7.4 Syneos Health Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.7.5 Syneos Health Recent Developments 7.8 PRA 7.8.1 PRA Profile 7.8.2 PRA Main Business 7.8.3 PRA Clinical CRO Services Products, Services and Solutions 7.8.4 PRA Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.8.5 PRA Recent Developments 7.9 Charels River 7.9.1 Charels River Profile 7.9.2 Charels River Main Business 7.9.3 Charels River Clinical CRO Services Products, Services and Solutions 7.9.4 Charels River Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.9.5 Charels River Recent Developments 7.10 Medpace 7.10.1 Medpace Profile 7.10.2 Medpace Main Business 7.10.3 Medpace Clinical CRO Services Products, Services and Solutions 7.10.4 Medpace Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.10.5 Medpace Recent Developments 7.11 Tigermed 7.11.1 Tigermed Profile 7.11.2 Tigermed Main Business 7.11.3 Tigermed Clinical CRO Services Products, Services and Solutions 7.11.4 Tigermed Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.11.5 Tigermed Recent Developments 7.12 Boji Medical Technology Co., Ltd 7.12.1 Boji Medical Technology Co., Ltd Profile 7.12.2 Boji Medical Technology Co., Ltd Main Business 7.12.3 Boji Medical Technology Co., Ltd Clinical CRO Services Products, Services and Solutions 7.12.4 Boji Medical Technology Co., Ltd Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.12.5 Boji Medical Technology Co., Ltd Recent Developments 7.13 Nanjing Huawe Medicine Technology Group co., LTD 7.13.1 Nanjing Huawe Medicine Technology Group co., LTD Profile 7.13.2 Nanjing Huawe Medicine Technology Group co., LTD Main Business 7.13.3 Nanjing Huawe Medicine Technology Group co., LTD Clinical CRO Services Products, Services and Solutions 7.13.4 Nanjing Huawe Medicine Technology Group co., LTD Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.13.5 Nanjing Huawe Medicine Technology Group co., LTD Recent Developments 7.14 JOINN Laboratories (China) Co., Ltd 7.14.1 JOINN Laboratories (China) Co., Ltd Profile 7.14.2 JOINN Laboratories (China) Co., Ltd Main Business 7.14.3 JOINN Laboratories (China) Co., Ltd Clinical CRO Services Products, Services and Solutions 7.14.4 JOINN Laboratories (China) Co., Ltd Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.14.5 JOINN Laboratories (China) Co., Ltd Recent Developments 7.15 ChemPartner 7.15.1 ChemPartner Profile 7.15.2 ChemPartner Main Business 7.15.3 ChemPartner Clinical CRO Services Products, Services and Solutions 7.15.4 ChemPartner Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.15.5 ChemPartner Recent Developments 7.16 WuXi AppTec 7.16.1 WuXi AppTec Profile 7.16.2 WuXi AppTec Main Business 7.16.3 WuXi AppTec Clinical CRO Services Products, Services and Solutions 7.16.4 WuXi AppTec Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.16.5 WuXi AppTec Recent Developments 8 Industry Chain Analysis 8.1 Clinical CRO Services Industrial Chain 8.2 Clinical CRO Services Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Clinical CRO Services Sales Model 8.5.2 Sales Channel 8.5.3 Clinical CRO Services Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Clinical CRO Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 Clinical CRO Services Product Introduction 1.2 Global Clinical CRO Services Market Size Forecast (2020-2031) 1.3 Clinical CRO Services Market Trends & Drivers 1.3.1 Clinical CRO Services Industry Trends 1.3.2 Clinical CRO Services Market Drivers & Opportunity 1.3.3 Clinical CRO Services Market Challenges 1.3.4 Clinical CRO Services Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Clinical CRO Services Players Revenue Ranking (2024) 2.2 Global Clinical CRO Services Revenue by Company (2020-2025) 2.3 Key Companies Clinical CRO Services Manufacturing Base Distribution and Headquarters 2.4 Key Companies Clinical CRO Services Product Offered 2.5 Key Companies Time to Begin Mass Production of Clinical CRO Services 2.6 Clinical CRO Services Market Competitive Analysis 2.6.1 Clinical CRO Services Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Clinical CRO Services Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical CRO Services as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Clinical Trial Design 3.1.2 Clinical Trial Execution 3.1.3 Clinical Trial Analysis 3.1.4 Other 3.2 Global Clinical CRO Services Sales Value by Type 3.2.1 Global Clinical CRO Services Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Clinical CRO Services Sales Value, by Type (2020-2031) 3.2.3 Global Clinical CRO Services Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Chemical Drug Research And Development 4.1.2 Cell And Gene Therapy Research And Development 4.1.3 Biopharmaceutical Research 4.1.4 Other 4.2 Global Clinical CRO Services Sales Value by Application 4.2.1 Global Clinical CRO Services Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Clinical CRO Services Sales Value, by Application (2020-2031) 4.2.3 Global Clinical CRO Services Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Clinical CRO Services Sales Value by Region 5.1.1 Global Clinical CRO Services Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Clinical CRO Services Sales Value by Region (2020-2025) 5.1.3 Global Clinical CRO Services Sales Value by Region (2026-2031) 5.1.4 Global Clinical CRO Services Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Clinical CRO Services Sales Value, 2020-2031 5.2.2 North America Clinical CRO Services Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Clinical CRO Services Sales Value, 2020-2031 5.3.2 Europe Clinical CRO Services Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Clinical CRO Services Sales Value, 2020-2031 5.4.2 Asia Pacific Clinical CRO Services Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Clinical CRO Services Sales Value, 2020-2031 5.5.2 South America Clinical CRO Services Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Clinical CRO Services Sales Value, 2020-2031 5.6.2 Middle East & Africa Clinical CRO Services Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Clinical CRO Services Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Clinical CRO Services Sales Value, 2020-2031 6.3 United States 6.3.1 United States Clinical CRO Services Sales Value, 2020-2031 6.3.2 United States Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Clinical CRO Services Sales Value, 2020-2031 6.4.2 Europe Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Clinical CRO Services Sales Value, 2020-2031 6.5.2 China Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.5.3 China Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Clinical CRO Services Sales Value, 2020-2031 6.6.2 Japan Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Clinical CRO Services Sales Value, 2020-2031 6.7.2 South Korea Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Clinical CRO Services Sales Value, 2020-2031 6.8.2 Southeast Asia Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Clinical CRO Services Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Clinical CRO Services Sales Value, 2020-2031 6.9.2 India Clinical CRO Services Sales Value by Type (%), 2024 VS 2031 6.9.3 India Clinical CRO Services Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 IQVIA 7.1.1 IQVIA Profile 7.1.2 IQVIA Main Business 7.1.3 IQVIA Clinical CRO Services Products, Services and Solutions 7.1.4 IQVIA Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.1.5 IQVIA Recent Developments 7.2 Covance 7.2.1 Covance Profile 7.2.2 Covance Main Business 7.2.3 Covance Clinical CRO Services Products, Services and Solutions 7.2.4 Covance Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.2.5 Covance Recent Developments 7.3 Parexel 7.3.1 Parexel Profile 7.3.2 Parexel Main Business 7.3.3 Parexel Clinical CRO Services Products, Services and Solutions 7.3.4 Parexel Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.3.5 Parexel Recent Developments 7.4 LabCorp 7.4.1 LabCorp Profile 7.4.2 LabCorp Main Business 7.4.3 LabCorp Clinical CRO Services Products, Services and Solutions 7.4.4 LabCorp Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.4.5 LabCorp Recent Developments 7.5 Fountain-Med 7.5.1 Fountain-Med Profile 7.5.2 Fountain-Med Main Business 7.5.3 Fountain-Med Clinical CRO Services Products, Services and Solutions 7.5.4 Fountain-Med Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.5.5 Fountain-Med Recent Developments 7.6 PPD 7.6.1 PPD Profile 7.6.2 PPD Main Business 7.6.3 PPD Clinical CRO Services Products, Services and Solutions 7.6.4 PPD Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.6.5 PPD Recent Developments 7.7 Syneos Health 7.7.1 Syneos Health Profile 7.7.2 Syneos Health Main Business 7.7.3 Syneos Health Clinical CRO Services Products, Services and Solutions 7.7.4 Syneos Health Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.7.5 Syneos Health Recent Developments 7.8 PRA 7.8.1 PRA Profile 7.8.2 PRA Main Business 7.8.3 PRA Clinical CRO Services Products, Services and Solutions 7.8.4 PRA Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.8.5 PRA Recent Developments 7.9 Charels River 7.9.1 Charels River Profile 7.9.2 Charels River Main Business 7.9.3 Charels River Clinical CRO Services Products, Services and Solutions 7.9.4 Charels River Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.9.5 Charels River Recent Developments 7.10 Medpace 7.10.1 Medpace Profile 7.10.2 Medpace Main Business 7.10.3 Medpace Clinical CRO Services Products, Services and Solutions 7.10.4 Medpace Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.10.5 Medpace Recent Developments 7.11 Tigermed 7.11.1 Tigermed Profile 7.11.2 Tigermed Main Business 7.11.3 Tigermed Clinical CRO Services Products, Services and Solutions 7.11.4 Tigermed Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.11.5 Tigermed Recent Developments 7.12 Boji Medical Technology Co., Ltd 7.12.1 Boji Medical Technology Co., Ltd Profile 7.12.2 Boji Medical Technology Co., Ltd Main Business 7.12.3 Boji Medical Technology Co., Ltd Clinical CRO Services Products, Services and Solutions 7.12.4 Boji Medical Technology Co., Ltd Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.12.5 Boji Medical Technology Co., Ltd Recent Developments 7.13 Nanjing Huawe Medicine Technology Group co., LTD 7.13.1 Nanjing Huawe Medicine Technology Group co., LTD Profile 7.13.2 Nanjing Huawe Medicine Technology Group co., LTD Main Business 7.13.3 Nanjing Huawe Medicine Technology Group co., LTD Clinical CRO Services Products, Services and Solutions 7.13.4 Nanjing Huawe Medicine Technology Group co., LTD Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.13.5 Nanjing Huawe Medicine Technology Group co., LTD Recent Developments 7.14 JOINN Laboratories (China) Co., Ltd 7.14.1 JOINN Laboratories (China) Co., Ltd Profile 7.14.2 JOINN Laboratories (China) Co., Ltd Main Business 7.14.3 JOINN Laboratories (China) Co., Ltd Clinical CRO Services Products, Services and Solutions 7.14.4 JOINN Laboratories (China) Co., Ltd Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.14.5 JOINN Laboratories (China) Co., Ltd Recent Developments 7.15 ChemPartner 7.15.1 ChemPartner Profile 7.15.2 ChemPartner Main Business 7.15.3 ChemPartner Clinical CRO Services Products, Services and Solutions 7.15.4 ChemPartner Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.15.5 ChemPartner Recent Developments 7.16 WuXi AppTec 7.16.1 WuXi AppTec Profile 7.16.2 WuXi AppTec Main Business 7.16.3 WuXi AppTec Clinical CRO Services Products, Services and Solutions 7.16.4 WuXi AppTec Clinical CRO Services Revenue (US$ Million) & (2020-2025) 7.16.5 WuXi AppTec Recent Developments 8 Industry Chain Analysis 8.1 Clinical CRO Services Industrial Chain 8.2 Clinical CRO Services Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Clinical CRO Services Sales Model 8.5.2 Sales Channel 8.5.3 Clinical CRO Services Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の医療機器・消耗品分野での最新刊レポート
本レポートと同じKEY WORD（demand）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
